Dr. Evans is a 20 year industry veteran and leads the Healthcare practice at SSR.  As a senior executive in the pharmaceuticals industry, Dr. Evans responsibilities ranged from corporate strategy to the pricing and distribution of the company’s products.  His variety of assignments provided a comparable variety of vantage points on the industry.  As an analyst with Sanford C. Bernstein, he was ranked #1 by both Bloomberg and Institutional Investor for his U.S. pharmaceuticals coverage – across all industries and coverage he was ranked one of the top 20 analysts worldwide.  Dr. Evans is the author of “Health and Capital” published in August of 2009.  He is a co-founder of Sector & Sovereign Research, LLC.

Media Coverage
Research Archive
Media Coverage

Media Coverage

In the Media

July 30, 2019 Pinning Down Prescription Drug Prices

November 26, 2018 Pharma-backed group attacks a controversial cost-shifting insurance tool by scaring employers

June 5, 2018 A new cost-shifting maneuver is causing average net prices for drugs to fall

April 18, 2018 Which drug makers are most vulnerable to a new cost-shifting maneuver?

March 30, 2018 Wholesale drug prices may be rising, but rebates are taking a bigger bite

October 11, 2017 J&J is struggling in Puerto Rico, but claims to be making progress

September 19, 2017 Brand-name drug prices are still rising, just not as fast as before

November 16, 2016 Drug prices don’t budge even after pressure from Congress

October 10, 2018 Get ready for a Rx drug-supplement war 

September 11, 2018 Copay Coupons and their Nemeses: What is Driving Drug Price Declines, and Who is Paying? 

September 4, 2018 – Insurance tactic drags down U.S. drug prices in second quarter: analyst

June 5, 2018 U.S. drug prices hit by insurer tactic against copay assistance: analysis

July 18, 2018 When insurers drop medications for cheap alternatives, the effects can be devastating for some patients

March 5, 2019 FDA chief Gottlieb resigns as agency battles teen vaping, opioid crisis

June 5, 2018 Drug prices are falling—but not necessarily in a way that helps patients

March 15, 2018 Which firms profit most from America’s health-care system

.

.

February 12, 2018 Trump’s big promises on drug costs followed by modest steps

August 9, 2017 Amid EpiPen price woes, alternatives emerge — but at a questionable cost

February 22, 2017 Lawsuit accuses drug makers of conspiring to hike insulin prices

April 27, 2016 Valeant CEO admits “regret” over drug price hikes

December 5, 2017 What the CVS-Aetna deal means for the future of health care

November 7, 2016 The bizarre reason two competing drug prices rose in tandem

May 12, 2016 Secret rebates, coupons and exclusions: how the battle over high drug prices is really being fought

March 18, 2016 A window into one of the most baffling things about drug prices

bloomberg-business-mag-logo

December 20, 2018 – Pharma Prepares to Raise Prices in 2019 With a Wink to Trump

July 10, 2018 – Drugmakers Cancel Price Hikes After California Law Takes Effect

May 3, 2018 Glaxo’s Advair Is the $100 Billion Asthma Drug That Won’t Die

November 7, 2017 This Is How Amazon Could Invade the Pharmacy Business

September 10, 2015 Big Pharma’s Foe Takes Victory Lap as Drug Price Increases Slow

May 8, 2014 Big Pharma’s Favorite Prescription: Higher Prices

Forbes-logo

June 20, 2016 A Market-Based Proposal for Controlling Drug Prices

June 12, 2014 Valeant Pharma’s Arguments About Drug Research Are Misleading And Wrong

May 22, 2014 Who’s The Best In Drug Research? 22 Companies Ranked

May 7, 2014 Is This How We’ll Cure Cancer?

December 26, 2013 Matt Herper’s Most-Read Stories Of 2013

December 5, 2013 ObamaCare Raises Health Insurance Premiums, Especially For The Young

January 31, 2013 The Flu Season Is A Shot In The Arm For Vaccine Makers?

July 9, 2012 Hidden Danger: Why The Supreme Court Ruling Might Make Medicaid Shrink

March 21, 2012 Why Big Pharma’s Constant Price Increases Could Backfire

July 7, 2011 Pfizer Decides Against Radical Surgery

June 1, 2011 A Pfizer Break Up? Maybe Not Such A Great Idea

May 19, 2010 Lipitor Factory Is One Pfizer Casualty

January 20, 2010 What’s Next For Health Care Companies?

FT 1

May 8, 2014 Sanofi’s success shows benefit of global approach in drugs R&D 

wsj-logo

February 5, 2019 Flip the Script: Drugmakers Blame Middlemen for Price Increases

March 25, 2018 Glaxo CEO Dispenses Bitter Pill to Fix R&D

May 2, 2017 Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out

April 30, 2017 Drug Makers Take Page From Hollywood to Spread the Risk

December 1, 2015 Why the U.S. Pays More Than Other Countries for Drugs

June 25, 2014 Sick Drawn to New Coverage in Health-Law Plans

June 18, 2014 – Premiums Rise at Big Insurers, Fall at Small Rivals Under Health Law

June 10, 2014 – Bid for Allergan Puts Valeant’s Research and Development Cuts Under Scrutiny

May 7, 2014 The Great Pharmaceutical Garage Sale of 2014 (Q&A with Richard Evans)

April 14, 2014 CBO Projects Lower Premiums in Health-Insurance Exchanges

September 3, 2013 The Morning Ledger: Health Care and Hiring Loom Large This Fall

September 25, 2012 Health Firms Size Up Election Outcomes

July 1, 2012 Health Law Battle Enters Round 2

June 29, 2012 How Low Might Medicare’s Drug Payout Go?

March 17, 2011 Drug Prices Rise Despite Calls for Cuts

March 17, 2011 Drug Price Increases Come As Companies Peer Over Patent Cliff

npr logo

February 26, 2019 Cat Bites The Hand That Feeds; Hospital Bills $48,512

February 26, 2019 Pharmaceutical Company CEOs Face Grilling In Senate Over High Drug Prices

September 21, 2016 Mylan CEO Claims EpiPens Aren’t As Profitable As Everyone Thinks

August 25, 2016 Discounts Aren’t Enough to Halt Outrage At High EpiPen Prices

January 25, 2016 Fight To Lower Drug Prices Forces Some To Switch Medication

May 16, 2013 Pfizer Goes Direct With Viagra Sales To Men

September 12, 2012 How Cheap Can Lipitor Get? Try Free

May 31, 2012 More Americans Are Checking Prices Before Getting Health Care

January 13, 2012 Drugmakers Boost Prices, Despite Political Risks

January 7, 2011 If Drug Copays Have You Down, Check For A Coupon

January 20, 2010 Prospects For Health Overhaul Dim After Massachusetts Vote

nyt logo
January 6, 2018 Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.

March 28, 2017 Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year

November 17, 2009 Analyst Doubts Health Overhaul Can Pass

 

bloomberg logo

February 22, 2010 Evans Interview on Obama Health-Care Plan: Video – Bloomberg

December 28, 2009 Evans Intervew on Health-Care Legislation: Video – Bloomberg

ap logo

May 25, 2012 Analysis: HMO stocks may struggle over health claim costs

Research Archive